Alivus Life Sciences Limited (NSE:ALIVUS)

Alivus Life Sciences Statistics

Total Valuation

NSE:ALIVUS has a market cap or net worth of INR 138.20 billion. The enterprise value is 132.28 billion.

Market Cap	138.20B
Enterprise Value	132.28B

Important Dates

The next confirmed earnings date is Thursday, May 14, 2026.

Earnings Date	May 14, 2026
Ex-Dividend Date	Sep 1, 2025

Share Statistics

NSE:ALIVUS has 122.74 million shares outstanding. The number of shares has increased by 0.01% in one year.

Current Share Class	122.74M
Shares Outstanding	122.74M
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	+0.24%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	11.03%
Float	30.84M

Valuation Ratios

The trailing PE ratio is 25.46 and the forward PE ratio is 22.78.

PE Ratio	25.46
Forward PE	22.78
PS Ratio	5.50
PB Ratio	4.58
P/TBV Ratio	4.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	24.33
EV / Sales	5.27
EV / EBITDA	17.04
EV / EBIT	18.58
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.02
Debt / EBITDA	0.08
Debt / FCF	n/a
Interest Coverage	133.74

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	21.98%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	4.57%
Revenue Per Employee	11.40M
Profits Per Employee	2.47M
Employee Count	2,203
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NSE:ALIVUS has paid 1.83 billion in taxes.

Income Tax	1.83B
Effective Tax Rate	25.19%

Stock Price Statistics

The stock price has increased by +0.37% in the last 52 weeks. The beta is 0.06, so NSE:ALIVUS's price volatility has been lower than the market average.

Beta (5Y)	0.06
52-Week Price Change	+0.37%
50-Day Moving Average	992.58
200-Day Moving Average	946.66
Relative Strength Index (RSI)	71.17
Average Volume (20 Days)	124,943

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:ALIVUS had revenue of INR 25.12 billion and earned 5.44 billion in profits. Earnings per share was 44.23.

Revenue	25.12B
Gross Profit	13.84B
Operating Income	7.12B
Pretax Income	7.27B
Net Income	5.44B
EBITDA	7.73B
EBIT	7.12B
Earnings Per Share (EPS)	44.23

Balance Sheet

The company has 6.53 billion in cash and 604.45 million in debt, with a net cash position of 5.92 billion or 48.26 per share.

Cash & Cash Equivalents	6.53B
Total Debt	604.45M
Net Cash	5.92B
Net Cash Per Share	48.26
Equity (Book Value)	30.15B
Book Value Per Share	245.82
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	609.68M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 55.09%, with operating and profit margins of 28.34% and 21.64%.

Gross Margin	55.09%
Operating Margin	28.34%
Pretax Margin	28.93%
Profit Margin	21.64%
EBITDA Margin	30.76%
EBIT Margin	28.34%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.45%.

Dividend Per Share	5.00
Dividend Yield	0.45%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.01%
Shareholder Yield	0.43%
Earnings Yield	3.93%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2